Because butorphanol (Stadol), a synthetic morphinan compound, has been
demonstrated in our laboratories to produce physical dependence and w
ithdrawal symptoms in rats, we have hypothesized that butorphanol has
rewarding properties indicative of abuse potential. To test this hypot
hesis, the effects of equimolar doses of butorphanol tartrate (0.5-5.0
mu g) and morphine sulfate (0.8-8.0 mu g) were assessed in inbred Lew
is male rats using the conditioned place preference (CPP) paradigm. Un
ilateral microinjections (1 mu l/inj) of saline or opioids were made i
nto the ventral tegmental area (VTA). Microinjections of saline to con
trols were associated with both sides of modified Skinner boxes, where
as opioid injections were associated only with the white chambers (les
s preferred side to the naive animals). Opioids were administered alte
rnating with saline in the drug-treated animals on alternating days. D
uring eight conditioning sessions the rats learned to associate light
and dark sides of the Skinner boxes with microinjections of opioids or
saline, respectively. Although all doses of morphine induced signific
ant preference over saline, only the higher doses of butorphanol (2.0-
5.0 mu g) produced significant conditioned place preference for the si
des of the chambers associated with the drugs. These results suggest t
hat, like morphine which is widely abused, butorphanol also has reward
ing properties, and, therefore, further investigations regarding its a
buse potential are necessary.